Abstact
The effect of alendronate on the bone tissue in male and female Wistar rats and senescent-accelerated OXYS rats with early development of osteoporosis was studied. The drug was applied at a dose of 0.84 mg/kg for 2 months starting from the age of 8 months. We found that the effect of the drug depended on genotype and sex of animals. It was maximally expressed in female OXYS rats as an increase in bond mineral density (BMD), which was initially decreased, and an elevation of the marker of bone formation osteocalcin in serum. In Wistar rats, the drug increased BMD in males only, whereas in females it decreased the osteocalcin level. The content of calcium in serum did not change and the known side effect of alendronate such as enhanced excretion of calcium with urine was expressed in male Wistar rats and in female of both strains. The response of OXYS rats to the application of the standard drug for osteoporosis treatment demonstrates that these rats can be used as a model of this disease, which is suitable for assessment of the efficacy of new therapeutic approaches.
Similar content being viewed by others
References
Ershov, K.I., Rusova, T.V., Falameeva, O.V., et al., Glycosaminoglycans of the Bone Matrix at Development of Osteoporosis in Premature Aging of OXYS Rats, Uspekhi Gerontol., 2009, vol. 22, no. 2, pp. 285–291.
Kolosova, N.G., Kutorgin, G.D., and Safina, A.F., Mineralization Peculiarities of the Bone Tissue of Premature Aging OXYS Rats, Byul. Eksper. Biol., 2002, no. 133, pp. 203–206.
Muraleva, N.A., Sadovoi, M.A., and Kolosova, N.G., Development Peculiarities of Osteoporosis in Premature Aging OXYS Rats, Uspekhi Gerontol., 2010, vol. 23, no. 2, pp. 233–242.
Falameeva, O.V., Sadovoi, M.A., Khrapova, Yu.V., and Kolosova, N.G., Structural-Functional Changes of Bone Tissue in Spinal Column and Extremities of OXYS Rats, Khirurgiya Pozvonochnika, 2006, vol. 1, pp. 88–94.
Adami, S., Prizzi, R., and Colapietro, F., Alendronate for the Treatment of Osteoporosis in Men, Calcif Tiss. Int., 2001, vol. 69, pp. 239–241.
Duque, G., Demontiero, O., and Troen, B.R., Prevention and Treatment of Senile Osteoporosis and Hip Fractures, Minerva Med., 2009, vol. 100, no. 1, pp. 79–94.
Fleisch, H., Bisphosphonates in Osteoporosis, J. Europ. Spine, 2003, vol. 12, no. 2, pp. 142–146.
Ho, Y.V., Frauman, A.G., Thomson, W., and Seeman, E., Effects of Alendronate on Bone Density in Men with Primary and Secondary Osteoporosis, Osteoporos Int., 2000, vol. 11, pp. 98–101.
Iwamoto, J., Takeda, T., Sato, Y., and Uzawa, M., Comparison of the Effect of Alendronate on Lumbar Bone Mineral Density and Bone Turnover in Men and Postmenopausal Women with Osteoporosis, Clin. Rheumatol., 2007, vol. 26, no. 2, pp. 161–167.
Orwoll, E., Ettinger, M., Weiss, S., et al., Alendronate for the Treatment of Osteoporosis in Men, N. Engl. J. Med., 2000, vol. 343, pp. 604–610.
Reinwald, S. and Burr, D., Review of Nonprimate, Large Animal Models for Osteoporosis Research, J. Bone Miner. Res., 2008, vol. 23, no. 9, pp. 1353–1368.
Ringe, J.D., Faber, H., and Dorst, A., Alendronate Treatment of Established Primary Osteoporosis in Men: Results of a 2-Year Prospective Study, J. Clin. Endocr. Metab., 2001, vol. 86, pp. 5252–5255.
Venediktova, A.A., Falameeva, O.V., Kolosova, N.G., et al., Cathepsin K and Matrix Metalloprotease Activities in Bone Tissue of the OXYS Rats During the Development of Osteoporosis, Biomedical Chem., 2009, vol. 3, no. 4, pp. 393–398.
Ward, L., Tricco, A.C., Phuong, P., et al., Bisphosphonate Therapy for Children and Adolescents with Secondary Osteoporosis, Cochrane Database Syst. Rev., 2007.
Wells, G.A., Cranney, A., Peterson, J., et al., Alendronate for the Primary and Secondary Prevention of Osteoporotic Fractures in Postmenopausal Women, Cochrane Database Syst. Rev., 2008.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © N.A. Muraleva, M.A. Sadovoi, N.G. Kolosova, 2011, published in Uspekhi Gerontologii, 2011, Vol. 24, No. 1, pp. 143–146.
Rights and permissions
About this article
Cite this article
Muraleva, N.A., Sadovoi, M.A. & Kolosova, N.G. The effect of alendronate on bone tissue of senescent-accelerated OXYS rats. Adv Gerontol 1, 352–355 (2011). https://doi.org/10.1134/S2079057011040126
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S2079057011040126